# David L. Porter — Patents explained on PatentBrief

David L. Porter has 2 landmark patents explained in plain English on PatentBrief.

- [How Genetically Modified T-Cells Fight CD19 Cancers](https://patentbrief.org/patent/us/9481728/compositions-and-methods-for-treatment-of-cancer) — granted 2016
  This patent describes how to create and use genetically modified human T cells that target and kill cancer cells expressing the CD19 protein, offering a new way to treat blood cancers.
- [How Genetically Modified T-Cells Attack Cancer](https://patentbrief.org/patent/us/9328156/use-of-chimeric-antigen-receptor-modified-t-cells-to-treat-cancer) — granted 2016
  This patent describes how human T cells are genetically engineered to express a special receptor (CAR) that specifically targets and kills cancer cells, particularly those with the CD19 marker, offering a new way to treat cancer.

**Full profile:** https://patentbrief.org/inventor/david-l-porter

---

_Source: PatentBrief — https://patentbrief.org. Plain-English explanations of US patents._